Janet M. Cowan

Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials

Sundar Jagannath, Paul G. Richardson, Pieter Sonneveld et al. · Leukemia · 2006 · 265 citations

Life Sciences, Hematology, Oncology +16

Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma.

Claude Turc‐Carel, Paola Dal Cin, Janusz Limon et al. · Proceedings of the National Academy of Sciences · 1987 · 239 citations · Full text

Life Sciences, Genetics, Oncology +13

Cytogenetic Analysis of Melanocytes From Premalignant Nevi and Melanomas

Janet M. Cowan, Ruth Halaban, U. Francka · JNCI Journal of the National Cancer Institute · 1988 · 193 citations

Pharmacy, Oncology, Pharmacology +17

Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype

Linda Kleeman, Diana W. Bianchi, Lisa G. Shaffer et al. · Prenatal Diagnosis · 2009 · 145 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence

Maja Sedic, Adam Skibinski, Nelson E. Brown et al. · Nature Communications · 2015 · 143 citations · Full text

Life Sciences, Genetics, Oncology +17